Skip to main content
. Author manuscript; available in PMC: 2018 Sep 4.
Published in final edited form as: Pharmacotherapy. 2017 Sep 4;37(9):1164–1171. doi: 10.1002/phar.1983

Table 1.

Baseline characteristics in cases versus matched controls.

Characteristic1 Cases (n=65) Controls (n=350) p value2
Age (years), mean (SD) 58.3 (16.0) 57.1 (16.8) 0.59
Gender (female) 33 (51) 190 (54) 0.60
Weight (kg), mean (SD) 80.4 (29.4) 80.1 (31.9) 0.96
BMI (kg/m2), mean (SD) 23.6 (20.0) 26.9 (25.2) 0.18
Heparin agent 0.92
 Heparin 59 (91) 319 (91)
 Enoxaparin 6 (9) 31 (9)
Race/ethnicity3 0.97
 White 55 (85) 298 (85)
 Black 1 (2) 6 (2)
 Asian 0 (0) 1 (0)
 Other 9 (14) 45 (13)
Percent ancestry3
 European (%) 88 (26) 89 (27) 0.88
 African (%) 11 (26) 10 (25) 0.68
 Native American (%) 1 (2) 2 (7) 0.32
4Ts Score, mean (SD)4 5.1 (0.9) - -

BMI indicates body mass index; cm, centimeters; kg, kilograms; SD, standard deviation.

1

Values represent number (percentage) unless otherwise specified

2

P values represent results of chi square and t-tests where appropriate

3

Race/ethnicity values are those determined by STRUCTURE based on ancestry informative markers (>90% ancestry).

4

4Ts scored according to American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Linkins et al. Chest 2012;141:e495S–530S)